1-4 of 4
Emily Blood, MS
Close
Sort by
Journal Articles

A Phase II Study of PS-341 for Patients with High Risk, Newly Diagnosed Multiple Myeloma: A Trial of the Eastern Cooperative Oncology Group (E2A02).

Angela Dispenzieri, MD, Emily Blood, MS, David Vesole, MD, Rafael Fonseca, MD, Natalie Callander, MD, Philip R. Greipp, MD
Journal: Blood
Blood (2005) 106 (11): 2546.
https://doi.org/10.1182/blood.V106.11.2546.2546
Published: 2005
Journal Articles

Comparison of Myeloma Cell Gene Expression Profiles Pre and Post Thalidomide - Dexamethasone Therapy Provides Insight into Potential Mechanisms.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica Haug, Michael Kline, PhD, Emily Blood, MS, Wee Joo Chng, John A. Lust, MD, Leif Bergsagel, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2005) 106 (11): 3480.
https://doi.org/10.1182/blood.V106.11.3480.3480
Published: 2005
Journal Articles

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica Haug, MD, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, Leif Bergsagel, MD, John A. Lust, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2005) 106 (11): 508.
https://doi.org/10.1182/blood.V106.11.508.508
Published: 2005
Journal Articles

Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica L. Haug, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, John A. Lust, MD, PhD, Leif Bergsagel, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2005) 106 (11): 1555.
https://doi.org/10.1182/blood.V106.11.1555.1555
Published: 2005